Search clinical trials for: Travoprost/Brinzolamide fixed combination

Total 292 results

Alcon Research

Terminated

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT

Ocular Hypertension | Glaucoma

Belgium
Alcon Research

Completed

A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

Italy
Aristotle University Of Thessaloniki
Alcon Research

Completed

24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol

Glaucoma
Alcon Research

Completed

IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma

United States
Alcon Research

Terminated

Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)

Intraocular Pressure

United States
Afyon Kocatepe University Hospital

Completed

Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma

Glaucoma, Open-Angle
Novartis Pharmaceuticals

Completed

Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma

Glaucoma

Korea, Republic of
Alcon Research
PPD

Terminated

1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT

Ocular Hypertension | Glaucoma

Mexico
Alcon Research

Completed

6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma
Alcon Research

Completed

Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy

Ocular Hypertension | Glaucoma
Alcon Research

Completed

Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Primary Open-angle Glaucoma | Pigment Dispersion Glaucoma

Germany
Aristotle University Of Thessaloniki
Alcon Research

Completed

24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost

Glaucoma

Greece
Alcon Research

Completed

Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma

Glaucoma

Argentina
Alcon Research

Withdrawn

Travacom Post Marketing Surveillance Study

Ocular Hypertension | Open-angle Glaucoma
University of Campinas, Brazil

Completed

Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG

Uveitis, Anterior | Cystoid Macular Edema

Brazil
Alcon Research

Completed

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America

Glaucoma
Alcon Research

Terminated

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil

Glaucoma

Brazil
Alcon Research

Withdrawn

Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia

Ocular Hypertension | Glaucoma
Alcon Research

Completed

Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada

Ocular Hypertension | Glaucoma | Open-angle Glaucoma
Alcon Research

Completed

Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy

Glaucoma

Germany
Alcon Research

Completed

Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol

Glaucoma

United States
University of Western Ontario, Canada
Pfizer

Completed

STITCH (Simplified Therapeutic Intervention To Control Hypertension)

Hypertension

Canada
International Union Against Tuberculosis and Lung...
United States Agency for International Development (USAID)

Unknown

Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis

Tuberculosis

Algeria, Bolivia, Colombia, Guinea, Mozambique, Nepal, Peru, Tanzania, Vietnam
Kasr El Aini Hospital

Completed

Bimatoprost/Timolol Versus Travoprost/Timolol

Glaucoma

Egypt
Allergan

Completed

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy

Ocular Hypertension | Glaucoma, Open-Angle

Spain
Alcon Research

Terminated

Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy

Glaucoma

Brazil
Alcon Research

Completed

Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
General Hospital of Athens Elpis

Completed

Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections

Eye Diseases | Intraocular Pressure | Injection Complication

Greece
Assiut University

Unknown

Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo

Vitiligo | Excimer Laser | Fractional CO2 Laser
Alcon Research

Terminated

Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®

Ocular Hypertension | Open-angle Glaucoma

United States
University Hospital of Patras

Completed

Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification

Cataract | Intraocular Pressure

Greece
Aristotle University Of Thessaloniki

Completed

24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination

Primary Open Angle Glaucoma | Exfoliation Syndrome

Greece
Alcon Research

Completed

Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
Alcon Research

Completed

AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure

Glaucoma

United States
Alcon Research

Completed

Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav

Glaucoma

Germany
Alcon Research

Completed

Adherence Assessment With Travalert Dosing Aid

Ocular Hypertension | Open-angle Glaucoma

Spain
Alcon Research

Completed

Safety and Efficacy of Changing to DuoTrav From Prior Therapy

Glaucoma

Germany
Alcon Research

Completed

Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure

Ocular Hypertension | Open Angle Glaucoma
Adapt Produtos Oftalmológicos Ltda.

Withdrawn

Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH

Ocular Hypertension | Open Angle Glaucoma

Brazil
Alcon Research

Completed

Glaucoma Adherence Study, Spain (GAS)

Primary Open Angle Glaucoma | Ocular Hypertension

Spain
Alcon Research

Completed

Glaucoma Adherence Study (GAS)

Primary Open Angle Glaucoma | Ocular Hypertension

France, Italy, Netherlands, United Kingdom
Alcon Research

Completed

Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®

Ocular Hypertension | Open Angle Glaucoma
Alcon Research

Completed

Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Open-Angle Glaucoma
Almirall, S.A.
proDERM GmbH

Completed

Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test (PPT4)

Psoriasis

Germany
Alcon Research

Completed

Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma
Rockefeller University
National Institute on Drug Abuse (NIDA)

Completed

Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs

Hepatitis C

United States
Alcon, a Novartis Company

Completed

Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution

Ocular Hypertension | Open-Angle Glaucoma

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US (XLT)

Ocular Hypertension | Glaucoma

United States
Alcon Research

Completed

SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)

Ocular Hypertension | Open-Angle Glaucoma

United States
University Hospital, Clermont-Ferrand
Merck Sharp & Dohme LLC

Completed

Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis (STREAGER)

Chronic HCV Infection

France

3

Subscribe